Results 51 to 60 of about 15,426 (247)
Specific Antibodies to Recombinant Allergens of \u3cem\u3eAspergillus fumigatus\u3c/em\u3e in Cystic Fibrosis Patients with ABPA [PDF]
, 2006 Background Aspergillus fumigatus, a widely distributed fungus, has been implicated in causing life threatening infections as well as severe asthma and allergic diseases in man.
Bansal, Naveen K. +3 more
core +1 more source
Immune responses to airborne fungi and non-invasive airway diseases. [PDF]
, 2014 Inhalation of fungal particles is a ubiquitous way of exposure to microorganisms during human life; however, this exposure may promote or exacerbate respiratory diseases only in particular exposure conditions and human genetic background.
Niculita-Hirzel, Hélène +2 more
core +1 more source
Clinical Case Reports, 2021 As diagnostic algorithms for cystic fibrosis (CF) continue to evolve, education of general practitioners is essential to prevent delayed diagnosis of CF and allow prompt referral to CF centers.
Patricia Choi +2 more
doaj +1 more source
Living well with a chronic respiratory disease [PDF]
, 2019 [Extract] Many patients we see as respiratory clinicians have a chronic respiratory condition and will therefore require long-term treatment and healthcare support with the main goal of care focusing on reducing symptoms and improving quality of life ...
Dobler, Claudia C
core +1 more source
Cureus, 2020 Allergic bronchopulmonary aspergillosis (ABPA) is an eosinophilic pulmonary disorder caused by a hypersensitivity reaction to Aspergillus fumigatus that manifests with uncontrolled asthma, peripheral blood eosinophilia, and radiological findings, such as
Amirseena Tolebeyan +3 more
semanticscholar +1 more source
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source
Allergic bronchopulmonary aspergillosis with coexistant aspergilloma: a case report
Journal of Medical Case Reports, 2010 Introduction The coexistence of allergic bronchopulmonary aspergillosis and aspergilloma is rare. Case presentation We present the case of a 56-year-old Caucasian man who worked as a farmer, with infiltrates in the right lower and middle lung lobes ...
Kern Izidor, Lopert Anton
doaj +1 more source
Journal of Genetic Engineering and Biotechnology, 2022 Background Among the most common causes of invasive aspergillosis and acute bronchopulmonary aspergillosis is Aspergillus fumigatus. Transmission with A.
Darakshan Jabin, Ajay Kumar
doaj +1 more source
Internal medicine, 2020 We herein report a 56-year-old woman who developed allergic bronchopulmonary aspergillosis (ABPA) possibly due to fungal exposure after disastrous heavy rainfall in Western Japan in 2018.
Hiroaki Matsuura +11 more
semanticscholar +1 more source
Pediatric Pulmonology, Volume 61, Issue 4, April 2026.ABSTRACT Objective This study aimed to evaluate 5‐year outcomes of a structured quality improvement (QI) program implemented as part of the standard of care at our CF center, focusing on changes in body mass index (BMI) and forced expiratory volume in 1 s (FEV₁) in pwCF followed at our institution.
S. Karabulut +14 more
wiley +1 more source